The Critically Ill Cirrhotic Patient
Evaluation and Management
Herausgegeben: Rahimi, Robert S.
Versandkostenfrei!
Versandfertig in 6-10 Tagen
65,99 €
inkl. MwSt.
PAYBACK Punkte
33 °P sammeln!
This text provides a comprehensive, state-of-the-art overview of the diagnosis and management of the critically ill cirrhotic patient. The book reviews recent data about risk factors for acute on chronic liver failure (including infection, renal dysfunction and acute alcoholic hepatitis), profiles the latest treatment strategies for the management of variceal bleeding, ascites, hepatocellular carcinoma and presents current and novel therapies for acute hepatic encephalopathy, and anticoagulation in liver disease. The volume also focuses on the changing etiology of liver disease, with an emphas...
This text provides a comprehensive, state-of-the-art overview of the diagnosis and management of the critically ill cirrhotic patient. The book reviews recent data about risk factors for acute on chronic liver failure (including infection, renal dysfunction and acute alcoholic hepatitis), profiles the latest treatment strategies for the management of variceal bleeding, ascites, hepatocellular carcinoma and presents current and novel therapies for acute hepatic encephalopathy, and anticoagulation in liver disease. The volume also focuses on the changing etiology of liver disease, with an emphasis on obesity and frailty/sarcopenia, and advances in surgical techniques, including living donor liver transplants and gender disparities in liver transplantation. Palliative care for the critically ill liver patient is also discussed in the book.
Written by experts in the field, The Critically Ill Cirrhotic Patient: Evaluation and Management is a valuable resource for clinicians, practitioners, health care providers, and researchers who encounter patients with chronic liver disease, including end-stage liver cirrhosis.
Written by experts in the field, The Critically Ill Cirrhotic Patient: Evaluation and Management is a valuable resource for clinicians, practitioners, health care providers, and researchers who encounter patients with chronic liver disease, including end-stage liver cirrhosis.
Andere Kunden interessierten sich für
